Like pls_老虎社区_美港股上老虎

Wee1993

2021-08-20

Like pls

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":836600181,"tweetId":"836600181","gmtCreate":1629472678543,"gmtModify":1631891398653,"author":{"id":3583061108651688,"idStr":"3583061108651688","authorId":3583061108651688,"authorIdStr":"3583061108651688","name":"Wee1993","avatar":"https://static.tigerbbs.com/91072e08047838cdc7da6472073f8c9c","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>Like pls&nbsp;</body></html>","htmlText":"<html><head></head><body>Like pls&nbsp;</body></html>","text":"Like pls","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/836600181","repostId":2160271025,"repostType":4,"repost":{"id":"2160271025","kind":"news","pubTimestamp":1629472454,"share":"https://www.laohu8.com/m/news/2160271025?lang=&edition=full","pubTime":"2021-08-20 23:14","market":"us","language":"en","title":"4 Stocks Insiders Are Selling","url":"https://stock-news.laohu8.com/highlight/detail?id=2160271025","media":"Benzinga","summary":"When insiders sell shares, it indicates their concern in the company’s prospects or that they view t","content":"<img src=\"https://s1.yimg.com/uu/api/res/1.2/uuel8MXZ67u5P3beVgfBWQ--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/Benzinga/8458419fd90ed89547b2be1234261dd6\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\">\nWhen insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.\nBelow is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.\n<a href=\"https://laohu8.com/S/GOOG\">Alphabet</a> \nThe Trade: <a href=\"https://laohu8.com/S/GOOGL\">Alphabet</a> Inc. (NASDAQ: GOOG) Director Larry Page disposed a total of 13889 shares at an average price of $2,751.73. The insider received $38,218,718.69 as a result of the transaction.\nWhat’s Happening: GE Appliances and Google signed a multi-year deal to build next-gen smart home appliances, Reuters reported.\nWhat Alphabet Does: Alphabet is a holding company, with Google, the Internet media giant, as a wholly owned subsidiary. Google generates 99% of Alphabet revenue, of which more than 85% is from online ads.\n<a href=\"https://laohu8.com/S/ADMA\">ADMA Biologics</a> \nThe Trade: ADMA Biologics, Inc. (NASDAQ: ADMA) 10% owner Perceptive Advisors Llc, Perceptive Life Sciences Master Fund Ltd, Joseph Edelman sold a total of 1781824 shares at an average price of $1.31. The insider received $2,333,780.88 from selling those shares.\nWhat’s Happening: The FDA recently approved ADMA Biologics BioCenters plasma collection facility in Maryville, Tennessee.\nWhat ADMA Biologics Does: <a href=\"https://laohu8.com/S/ADMA\">ADMA Biologics Inc</a> is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases.\nTrimble \nThe Trade: <a href=\"https://laohu8.com/S/TRMB\">Trimble Navigation</a> (NASDAQ: TRMB) Director Steven Berglund sold a total of 60000 shares at an average price of $88.40. The insider received $5,304,118.61 as a result of the transaction.\nWhat’s Happening: Trimble reported a new $750 million buyback program.\nWhat Trimble Does: Trimble Inc provides location-based solutions that are used in global positioning system (GPS), laser, optical and inertial technologies.\nEli Lilly \nThe Trade: <a href=\"https://laohu8.com/S/LLY\">Eli Lilly and</a> Company. (NYSE: LLY) 10% owner Lilly Endowment Inc sold a total of 15430 shares at an average price of $274.31. The insider received $4,232,603.30 from selling those shares.\nWhat’s Happening: The FDA recently approved Eli Lilly - Boehringer Ingelheim's Jardiance (empagliflozin) 10 mg for heart failure.\nWhat Eli Lilly Does: Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, oncology, and immunology.","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Stocks Insiders Are Selling</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Stocks Insiders Are Selling\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-20 23:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/4-stocks-insiders-selling-120353734.html>Benzinga</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nWhen insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. ...\n\n<a href=\"https://finance.yahoo.com/news/4-stocks-insiders-selling-120353734.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/5918b54af9d1fdfb3186789692d900cd","relate_stocks":{"GOOGL":"谷歌A","LLY":"礼来","ADMA":"ADMA Biologics Inc","GOOG":"谷歌","TRMB":"天宝导航"},"source_url":"https://finance.yahoo.com/news/4-stocks-insiders-selling-120353734.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2160271025","content_text":"When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.\nBelow is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.\nAlphabet \nThe Trade: Alphabet Inc. (NASDAQ: GOOG) Director Larry Page disposed a total of 13889 shares at an average price of $2,751.73. The insider received $38,218,718.69 as a result of the transaction.\nWhat’s Happening: GE Appliances and Google signed a multi-year deal to build next-gen smart home appliances, Reuters reported.\nWhat Alphabet Does: Alphabet is a holding company, with Google, the Internet media giant, as a wholly owned subsidiary. Google generates 99% of Alphabet revenue, of which more than 85% is from online ads.\nADMA Biologics \nThe Trade: ADMA Biologics, Inc. (NASDAQ: ADMA) 10% owner Perceptive Advisors Llc, Perceptive Life Sciences Master Fund Ltd, Joseph Edelman sold a total of 1781824 shares at an average price of $1.31. The insider received $2,333,780.88 from selling those shares.\nWhat’s Happening: The FDA recently approved ADMA Biologics BioCenters plasma collection facility in Maryville, Tennessee.\nWhat ADMA Biologics Does: ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases.\nTrimble \nThe Trade: Trimble Navigation (NASDAQ: TRMB) Director Steven Berglund sold a total of 60000 shares at an average price of $88.40. The insider received $5,304,118.61 as a result of the transaction.\nWhat’s Happening: Trimble reported a new $750 million buyback program.\nWhat Trimble Does: Trimble Inc provides location-based solutions that are used in global positioning system (GPS), laser, optical and inertial technologies.\nEli Lilly \nThe Trade: Eli Lilly and Company. (NYSE: LLY) 10% owner Lilly Endowment Inc sold a total of 15430 shares at an average price of $274.31. The insider received $4,232,603.30 from selling those shares.\nWhat’s Happening: The FDA recently approved Eli Lilly - Boehringer Ingelheim's Jardiance (empagliflozin) 10 mg for heart failure.\nWhat Eli Lilly Does: Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, oncology, and immunology.","news_type":1},"isVote":1,"tweetType":1,"viewCount":261,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":7,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/836600181"}